- Home
- / Novaremed
Novaremed
Total Funding
$13.3 M
Novaremed Summary
Company Summary
- Overview
- Novaremed is clinical-stage biopharmaceutical company. It develops an orally active non-opioid small molecule to treat diabetic neuropathic pain.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Basel, CH | view all locations
- Website
- http://www.novaremed.com/
- Cybersecurity rating
Table of Contents
Key People
Isaac Kobrin, Chairman
LocationsView all
1 location detected
Basel, BS HQ
Switzerland
Teichgässlein 9